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Abstract
Primary ovarian insufficiency (POI) is a critical fertility defect characterized by an anticipated and silent impairment of the
follicular reserve, but its pathogenesis is largely unexplained. The frequent maternal inheritance of POI together with a
remarkable dependence of ovarian folliculogenesis upon mitochondrial biogenesis and bioenergetics suggested the
possible involvement of a generalized mitochondrial defect. Here, we verified the existence of a significant correlation
between blood and ovarian mitochondrial DNA (mtDNA) content in a group of women undergoing ovarian
hyperstimulation (OH), and then aimed to verify whether mtDNA content was significantly altered in the blood cells of
POI women. We recruited 101 women with an impaired ovarian reserve: 59 women with premature ovarian failure (POF)
and 42 poor responders (PR) to OH. A Taqman copy number assay revealed a significant mtDNA depletion (P,0.001) in
both POF and PR women in comparison with 43 women of similar age and intact ovarian reserve, or 53 very old women
with a previous physiological menopause. No pathogenic variations in the mitochondrial DNA polymerase c (POLG) gene
were detected in 57 POF or PR women with low blood mtDNA content. In conclusion, blood cell mtDNA depletion is a
frequent finding among women with premature ovarian aging, suggesting that a still undetermined but generalized
mitochondrial defect may frequently predispose to POI which could then be considered a form of anticipated aging in
which the ovarian defect may represent the first manifestation. The determination of mtDNA content in blood may become
an useful tool for the POI risk prediction.
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Introduction
Primary ovarian insufficiency (POI) is a critical fertility defect
characterized by an anticipated impairment of the follicular
reserve [1,2]. This process is generally silent without evident
menstrual irregularity so that women are diagnosed with POI due
to the premature cessation of menses (secondary amenorrhea, SA)
before 40 years of age in the stage of complete follicular depletion
(premature ovarian failure, POF or overt POI).
The cause of POI remains obscure in most women [3,4]. A
strong genetic component in idiopathic POI pathogenesis is
revealed by the frequent familiarity (30–40% of total cases) for this
disease [5], with mothers and daughters experiencing a premature
ovarian aging and an anticipation of menopause. Among the
familial cases, the maternal inheritance of the ovarian defect is
prevalent (about 60%) [5,6]. This observation together with the
known association of POF with X-chromosomal abnormalities
have prompted studies on the possible involvement of X-linked
genes in POI pathogenesis [4,7,8]. However, the mitochondrial
material of the zygote has a maternal origin and also mitochon-
drial diseases may have a maternal transmission. Noteworthy,
mitochondrial defects are strongly associated with physiological or
pathological tissue aging, and can lead to altered metabolism,
impaired activity and/or accelerated degeneration [9,10].
Mitochondrial biogenesis and bioenergetics play an essential
role in oocyte maturation and embryo development [11,12].
Mature oocytes require one of the highest number of mitochon-
dria among all tissues in the body, and mitochondrial DNA copy
number per oocyte has been shown to be strictly associated to the
probability to develop a zygote [13,14]. In line with these findings,
intracytoplasmatic transfer of mitochondria markedly improves
the chances of pregnancy [12,13]. In addition, a marked
mitochondrial depletion in the oocyte has been observed in
women with poor recoveries of fertilizable oocytes after ovarian
hyperstimulation [15] and, importantly, also in cases of ovarian
insufficiency [16]. In addition, it has been reported that granulosa
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cells from women above 38 years of age have a diminished
number of mitochondria when compared to those from younger
fertile women [17]. The whole of these data indicate that a
reduction in the number of intact mitochondria correlates with
ovarian aging thus suggesting that a weakened respiratory chain
activity may be involved in the anticipated impairment of ovarian
reserve.
A correlation between mitochondrial diseases and POI has been
observed both in animals and in humans [18–21]. In particular,
germline mutations in the mitochondrial DNA (mtDNA) poly-
merase-c (POLG; MIM 174763) gene cause a generalized mtDNA
replication impairment and mitochondrial depletion and are
associated with phenotypes variably including neurological and
muscular defects, diabetes and POI.
The aim of the present study was to verify whether the content of
mtDNA is significantly reduced in the blood cells of women with a
prematurely impaired ovarian reserve. Therefore, we verified the
possible existence of a correlation between blood and ovarian
mtDNA content and then evaluated mtDNA content in peripheral
blood cells ofwomenwithPOFor an anticipated impairment of their
ovarian reserve and in two control groups: one constitutedbywomen
with intact ovarian reserve and the second by very old women
reporting a physiological menopause. Since responsiveness to
ovarian hyper-stimulation is currently believed to be the most
appropriate surrogate way to assess ovarian reserve [22], women
belonging to the impaired and intact ovarian reserve groups were
recruitedamongpatientsundergoing in vitro fertilization (IVF)cycles.
Materials and Methods
Approval for the study was obtained by the local Institution
review board and all subjects gave their informed consent for
granulosa cells (GCs) and/or blood sampling and genetic analysis.
Subjects
In a subgroup of 11 women undergoing in vitro fertilization (IVF)
protocolsweobtainedbothGCsandbloodcells inorder todetermine
the existence of a possible correlation between ovarian and blood
mtDNAcontent.Then, blood sampleswere obtained in three groups
ofwomenof comparable youngageandonegroupofoldwomenwith
physiologicalmenopause (Table1).Thefirstgroupwasconstitutedby
59 women with idiopathic POF,17 with primary and 42 with
secondary amenorrhea andFSHserum levels exceeding40 IU/Lon
at least two determinations [23]. The other 2 groups were selected
amongwomen undergoing ovarian hyperstimulation for IVF cycles.
Onegroupwasconstitutedbypoor responderwomendeveloping few
co-dominant follicles andretrieving few (,5)oocytesdespite elevated
gonadotropindosages (.300 IUperday) (PR;n= 42).Theotherwas
the group of control women, selected among those undergoing
ovarian hyperstimulation using gonadotropin dosages#250 IUand
retrieving$5 oocytes (Normal Responders, NR, n= 43). In both of
these groups themain indication for IVFweremale and tubal factors
(88% inNRand 74% inPR). Finally another group is represented by
very old control women with physiological menopause beyond
48 years of age (CPM, n=53). Patients with ovarian cysts and/or
those who were operated for ovarian cysts were excluded from all
groups. All patients were of Caucasian origin.
A blood sample was obtained from selected patients prior to the
initiation of medical treatments (ovarian hyper-stimulation or
hormone replacement therapy). Selection of patients with com-
promised ovarian reserve and controls was initially based on the
outcome of previous ovarian hyperstimulation cycles, the antral
follicle count (AFC on both ovaries ,8) and the hormonal tests
(day 3 serum FSH .12 U/L). The appropriateness of their
inclusion was confirmed after the treatment cycle.
MtDNA Determination in Circulating Blood Cells
Whole blood samples for the determination of mtDNA content
were collected in EDTA-containing tubes. In these samples, the
hemogramparameters includingwhitebloodcell (NR:6,07461,352;
PR:6,11661,320; POF: 7,43361,783; CPM: 5,91761,441) and
platelet (NR:212,040656,350; PR:219,036652,389;
POF:211,571641,279;CPM:213,844661,953) countswere similar
in the different groups, a finding against the potential interference by
significant variations in platelet count. The blood samples were
immediately stored at 220uC and thawed simultaneously for
mtDNA content determination. Total genomic DNA was isolated
from whole-blood specimens by the Wizard Genomic DNA
Purification Kit (Promega). MtDNA content was determined
utilizing a quantitative real-time PCR (QPCR) by the Taqman
method (AppliedBiosystem9700 HTSequentionDetectionSystem)
similarly to previously described protocols [24]. Specific probeswere
used to amplify a fragment of the mitochondrial D-loop region,
Hs02596861_s1 MT-7S (Applied Biosystems), or a fragment of the
nuclear genomic RNAse P, 4316844 RNAse P VIC (Applied
Biosystems). PCR reactions were performed according to standard
conditions for Taqman (Applied Biosystems): 50uC for 29; 95uC for
109; 40 cycles at 95uC 1599, 60uC 19. PCR assays were performed in
triplicate for each DNA sample. Real-time PCR efficiencies were
calculated from the given slopes in LightCycler software. The
corresponding real-time PCR efficiencies (E) of one cycle in the
exponential phase was calculated according to the equation:
E= 10[21/slope]. Investigated genes showed high real-time PCR
efficiency rates; for D-Loop, 1.90 and RNAse P, 1.89 in the
investigated range from 0.40 to 100 ng DNA input (n = 5) with high
linearity (Pearson correlation coefficient r.0.98). We then deter-
mined the expression of mtDNA copy number relative to nuclear
DNAusing the efficiency correctionmethod as described by Pfaffl et
co [25]:
ratio~E targetð Þ{(Ct target)=E endogenousð Þ{(Ct endogenous)
~1:9{ CtMT 7Sð Þ=1:89{ CtRNAse Pð Þ
The primary endpoint of the study was the mtDNA content
evaluation in women with intact and compromised ovarian
reserve. Assumptions to determine the sample size included a
type I and II error of 0.05 and 0.20, respectively.
Analysis of Mitochondrial DNA Polymerase c (POLG)
Gene
POLG gene was analyzed by PCR amplification using intronic
primers as previously described [26], and subsequently sequenced
by automated nucleotide sequencing with the Big Dye terminator
Ready Reaction Kit version 3.1 on a 3100 Genetic analyzer
automatic sequencer (Applied Biosystem, CA, USA). The analysis
was limited to the exons 7,8,17,18,21 on the basis of the reported
mutations in the POLG gene in association with POI
[19,21,27,28].
Results
In 11 women undergoing IVF protocols, the blood cell
mtDNA/nDNA copy number correlated significantly (p = 0.008)
with that of their GCs (Figure 1).
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Age and BMI of NR, PR and POF women were comparable,
though POF women tended to be younger (Table 1). CPM women
were instead very old, 9061.3 years, but had a BMI, 2564 kg/
m2, similar to that of the other groups. Consistently with diagnosis,
POF women had smaller ovaries without antral follicles in most
cases. Antral follicle counts (AFC) and ovary volumes at
ultrasound were lower in PR women, as compared to NR women.
Each DNA sample was run in at least three distinct Taqman
assays in triplicate. Intra- and inter-assay coefficients of variability
were ,9.6% and ,15.2%, respectively. Kurtosis and skewness
indexes of the content in mtDNA were consistent with a normal
distribution within the groups but variances differed. Data were
thus compared using ANOVA test and Dunnett (T3) post-hoc test.
The mean 6SE of the mtDNA/nDNA copy number was
significantly lower in women with an impaired ovarian reserve
(POF: 28.6561.8; PR: 52.466.6; p,0.0001), in comparison to
control women with an intact ovarian reserve (NR: 176.0618.4)
(Figure 2). In addition, the mtDNA/nDNA copy number was
significantly higher in NR versus CPM (CPM: 69.663.1)
(p,0.0001) and in CPM versus POF women (p,0.01). Instead,
the Dunnett (T3) post-hoc test showed statistically significant
differences for all comparisons, including PR versus POF
(p = 0.005) or CPM versus PR (p = 0.014).
Considering the range of mtDNA/nDNA copy number
observed in CPM women, lower values were found in 0/43
(0%) NR women, 19/42 (45%) PR and 38/59 (64%) POF. The
analysis of POLG gene did not reveal any pathogenic variation in
the 57 (38 POF and 19 PR) women with a mtDNA/nDNA copy
number below the lower limit observed in the control groups.
Discussion
In this study, we observed a significant correlation between
ovarian and blood mtDNA content and then found a diminished
mtDNA copy number in peripheral blood cells of women with an
impaired ovarian reserve compared to controls. A biological
grading clearly emerged showing the lowest levels in women with
POF and the highest in those with conserved ovarian function.
Interestingly, an intermediate level of mtDNA/nDNA copy
number was found in women with a poor response to ovarian
hyperstimulation (PR). The control groups of the present study
consisted of women with a normal response to ovarian
hyperstimulation (NR) and very old women with physiological
menopause (CPM). Since aging is a condition associated with a
progressive and generalized mitochondrial depletion [29–31], it is
reasonable that mean mtDNA/nDNA copy number in old CPM
women was found significantly lower than in young NR ones.
However, the mtDNA amount of CPM women was always
included within the range observed in NRs and significantly higher
than that of young women with a premature impairment of their
ovarian reserve. Therefore, a still undetermined mitochondrial
DNA damage might represent a defect predisposing to premature
ovarian insufficiency.
Since the reduction of the mtDNA/nDNA copy number was
seen in the blood cells of subjects with compromised ovarian
reserve and POF this defect appears as an intrinsic feature of the
women. Though the defects of mitochondrial metabolism cause a
wide range of human diseases affecting several tissues [32], the
affected women in this study did not report any systemic
manifestation at enrolment. One possible explanation for this
incongruity is that the entity of the defect detected in this study is
detrimental in the ovary while being tolerable for the other tissues.
There is indeed evidence suggesting that biochemical dysfunction
and consequent systemic manifestations occur only below a
threshold level [32,33] and ovarian tissue may be particularly
susceptible to the risks associated with a relative mitochondrial
DNA depletion. Consistently, folliculogenesis would require the
bioenergetic support of a large number of mitochondria in both
germinal and granulosa cells [16,17]. Ultrastructural studies in
human germinal cells showed that the number of mitochondria
dramatically increases from about 10 in primordial germ cells to
more than 100,000 in mature oocytes [34,35]. This phenomenon
Table 1. Anagraphical, clinical and biochemical parameters in the four groups of subjects.
Parameters Group 1: POF (n =59)
Group 2: PR (n =42)
(,5 eggs retrieved)
Group 3: NR (n=43)
($5 eggs retrieved) Group 4: CPM (n=53)
Age in years at blood sampling
mean 6SE (range)
29.261.8* (15–41) 34.462.6 (27–39) 3362.9 (27–38) 9061.3 (82–105)
Age in years at menopause
mean 6SE (range)
28.661.7 (14–39) – – 50.960.3 (48–58)
FSH (U/L) mean 6SE (range) 94.866.2* (30.2–160.0) 16.269.8 (5.1–53.0) 6.762.0 (1.9–12.7) 88.366.4 (69.0–105.2)
Ovarian volume (ml) 4.262.9* 5.462.8** 8.063.7 –
AFCa 0–1* 2.761.3** 7.362.7 –
aAntral Follicle Count per ovary.
*p,0.03 vs PR and NR.
**p,0.05 vs NR.
doi:10.1371/journal.pone.0042423.t001
Figure 1. Correlation between peripheral blood and ovarian
granulosa cell (GC) mitochondrial DNA content. Total DNA
isolated from whole blood and GCs of a total of 11 women has been
quantified by real-time quantitative PCR analysis using the RNAse P as
an endogenous control. Data were analyzed by using comparative Ct
method [25] and are expressed as relative quantification of mitochon-
drial on nuclear DNA copy numbers (mtDNA/nDNA). Regression analysis
was obtained by GraphPad Prism 5.0.
doi:10.1371/journal.pone.0042423.g001
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correlating with a progressive increment of respiratory chain
activity and oxygen consumption during follicle maturation [36–
38]. In addition, Luoma et al. reported a relevant incidence of
POF in women with POLG mutations, a protein essential for
mtDNA replication [19]. Pagnamenta et al. recently confirmed
this finding [21] and suggested to screen POF women for possible
genetic mechanisms of mtDNA depletion even in the absence of
evident manifestations such as the progressive external ophtalmo-
plegia (PEO). However, we could not find any pathogenic
variations of POLG gene in POF or PR women with impaired
mtDNA/nDNA copy number, thus suggesting that other mech-
anisms cause the mitochondrial DNA depletion in these women.
Based on these findings, POI might be interpreted as a
condition of anticipated aging in which the ovarian defect may
represent the first manifestation. In contrast, fertility beyond the
age of 40 might be associated with longevity. Accordingly,
centenarian women have been described to be four times more
likely to have had children while in their forties than 73 year-old
women [39]. This finding was recently confirmed by a compar-
ative study of women from three large historical databases [40].
Interestingly, also the relatives of old mothers were shown to
survive longer indicating the involvement of inheritable traits [41].
Our findings may then represent a suitable explanation for the
correlation between late female fertility and longevity, and may
also have implications regarding the theoretical basis of meno-
pause and human lifespan. In line with this view stands the fact
that a decreased fertility generally occurs before death in all female
animals, and only human females go into menopause nowadays
30–50 years before death thanks to the recent progress of
preventive medicine and therapeutics. These observations in
humans are consistent with selection experiments in Drosophila in
which the ability to produce eggs later in life is correlated with
greater life expectancy [42].
Here, the difference in mtDNA content between POF/PR
women and NR control women of similar age was highly
significant with overlaps that were in several assays limited to
about half of the cohorts. Since menopause has been repeatedly
shown to arise earlier in women with a reduced responsiveness to
ovarian hyperstimulation [43–45], blood cell mtDNA/nDNA
copy number determination might represent a valuable test
predicting the premature cessation of menses and ovarian failure
in the occult phase of the disease, when the currently available
tests are still not sufficiently efficient [1,2,4,22].
In conclusion, the blood and ovarian mtDNA/nDNA copy
numbers appear to be correlated and a diminished mtDNA
content was found in peripheral blood cells of women with an
impaired ovarian reserve. Therefore, POI may frequently occur as
a consequence of a generalized and still undetermined mitochon-
drial defect in which the ovary appears as the first affected tissue.
Finally, we propose the blood mtDNA/nDNA copy number
determination as a promising tool for the prediction either of the
POI risk or the poor response to ovarian hyperstimulation.
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